P
Paul S. Donnelly
Researcher at University of Melbourne
Publications - 215
Citations - 7933
Paul S. Donnelly is an academic researcher from University of Melbourne. The author has contributed to research in topics: Copper & Biodistribution. The author has an hindex of 45, co-authored 202 publications receiving 6785 citations. Previous affiliations of Paul S. Donnelly include University of Western Australia & University of Cambridge.
Papers
More filters
Journal ArticleDOI
Rhenium diazenide ternary complexes with dithiocarbamate ligands: towards new rhenium radiopharmaceuticals
TL;DR: Cyclic voltammetry measurements in dimethyl formamide show that the rhenium diazenido-dtc complexes undergo a quasi-reversible oxidation tentatively assigned to a ReIII/ReIV oxidation.
Journal ArticleDOI
Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer
Asif Noor,Jessica Van Zuylekom,Stacey E Rudd,Kelly Waldeck,Peter Roselt,Mohammad B. Haskali,Michael P Wheatcroft,Eddie Yan,Rodney J. Hicks,Rodney J. Hicks,Carleen Cullinane,Carleen Cullinane,Paul S. Donnelly +12 more
TL;DR: The ligands presented here, which can be labeled with either gallium-68 or zirconium-89, have the potential to increase the number of clinical sites that can perform diagnostic PET imaging.
Journal ArticleDOI
Improved non-invasive positron emission tomographic imaging of chemotherapy-induced tumor cell death using Zirconium-89-labeled APOMAB®
Vasilios Liapis,William Tieu,Stacey E Rudd,Paul S. Donnelly,Nicole L Wittwer,Michael P. Brown,Michael P. Brown,Michael P. Brown,Alexander H. Staudacher,Alexander H. Staudacher +9 more
TL;DR: The radionuclide/chelator combination of [ 89 Zr] Zr IV and DFOSq is preferred for the imminent clinical evaluation of chDAB4 as a selective tumor cell death radioligand for post-chemotherapy tumor uptake.
Journal ArticleDOI
Rhenium and technetium complexes of thioamide derivatives of pyridylhydrazine that bind to amyloid-β plaques.
Scott P Fletcher,Asif Noor,James L. Hickey,Catriona McLean,Jonathan M. White,Paul S. Donnelly +5 more
TL;DR: New radioactive technetium-99 m complexes that bind to amyloid-β plaques that have the potential to assist in diagnosis of cerebral amyloids angiopathy using single-photon-emitted computed tomography (SPECT) imaging are designed.
Journal ArticleDOI
Charge neutral rhenium tricarbonyl complexes of tridentate N-heterocyclic carbene ligands that bind to amyloid plaques of Alzheimer's disease
TL;DR: Two tridentate ligand systems bearing N-heterocyclic carbene (NHC), amine and carboxylate donor groups coupled to benzothiazole- or stilbene-based amyloid binding moieties show that the complexes bound efficiently toAmyloid-β fibrils and some evidence of binding to amyloids-β plaques is shown.